The House Judiciary Committee held a hearing today on the Oversight of the Federal Trade Commission (FTC). The hearing focused on FTC chair Lina Khan and FTC’s market overreach and centralization of power.
Read MoreTAPP recently submitted comments to the Senate HELP Committee in response to Senator Bernie Sanders’s request for public input on the proposed “reasonable pricing” scheme.
Read MoreResearch firm Vital Transformation modeled the impacts of government mandated drug pricing schemes currently proposed as the Smart Prices Act (SPA). The SPA would impose government price setting for certain Medicare drugs at only five years after initial FDA approval.
Read MoreTAPP submitted comments to the USPTO in response to their request for public input on proposed rule changes regarding discretionary institution practices, petition word-count limits, and settlement practices for America Invents Act trial proceedings before the Patent Trial and Appeal Board (PTAB).
Read MoreA recent report from Vital Transformation estimated and modeled the Inflation Reduction Act’s (IRA) impact on innovation and the ability of the life science industry to create new medicines
Read MoreA recent American Edge Project survey polled U.S. and European voters on domestic and foreign technology issues.
Read MoreThe American Edge Project (AEP), a coalition of two dozen domestic organizations, which includes the Trade Alliance to Promote Prosperity, has released a policy report underscoring the importance of maintaining a free and open internet amid the mounting threat posed by digital autocracies such as China and Russia.
Read MorePresident Biden reignited the Cancer Moonshot program in February 2022, announcing a national goal of cutting the death rate from cancer by at least 50 percent over the next 25 years. This is a noble and important goal that Americans can get behind. Medical innovators will be essential to the fight against cancer over the next 25 years.
Read MoreTariffs should be respected or repealed—not flouted. TAPP launched the “Tariff Integrity” initiative to urge the U.S. Trade Representative to crack down on foreign businesses evading tariffs on aftermarket automobile parts and to fight for tariff integrity.
Read MoreThe Trade Alliance to Promote Prosperity sent a letter to members of the U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee, urging the enactment of Pharmacy Benefit Manager reforms.
Read MoreTAPP recently submitted comments to the U.S. International Trade Commission to express concerns with a possible expansion of the TRIPS waiver beyond COVID-19 vaccines.
Read MoreThe Trade Alliance to Promote Prosperity signed a letter in support of the Pharmacy Benefit Manager (PBM) Project, which aims to reduce prescription drug costs for American patients and stop PBMs’ exploitative practices.
Read MoreApril 26 is World Intellectual Property Day. Started in 2000, World IP Day offers an opportunity to join with people around the world to consider how intellectual property (IP) enables and enlivens the innovation and creativity that drives human progress.
Read MoreThe Senate HELP committee meets today, March 22, to discuss the price of COVID-19 vaccines. Trade Alliance to Promote Prosperity has written to Senate HELP Committee members to express our concerns with anti-innovation policies and to urge committee members to support patent protections.
Read MoreLast week, President Biden unveiled his new budget proposal in front of Congress. The proposal calls for a rapid expansion of prescription drug provisions found in the Inflation Reduction Act. These provisions look appealing at first glance, but the consequences would be disastrous.
Read MoreOn February 23, 2023, the Trade Alliance to Promote Prosperity responded to a U.S. Patent and Trade Office Request for Comments on “USPTO Initiatives to Ensure the Robustness and Reliability of Patent Rights.”
Read MoreThe Trade Alliance to Promote Prosperity has written a letter to members of the U.S. Senate Judiciary Committee, urging them to protect American intellectual property rights and oppose S. 150, "A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes," which would put at risk U.S. global leadership in medical and biopharmaceutical research and development (and thus also patients).
Read MoreEarlier this month, the U.S. Patent and Trademark Office (USPTO) and the U.S. Food and Drug Administration (FDA) held a joint listening session, the latest in their recent collaborative efforts jumpstarted by an executive order issued by President Biden.
Read MoreWith the rise of digital platforms and the increasing dependence of small businesses on technology to reach consumers, it is crucial that American policymakers take steps to ensure that small businesses are not hindered by high costs and restrictive regulations.
Read MoreTechnological innovation is the core of our modern economy, and it is essential that American policy initiatives promote technological innovation in order to maintain our competitive edge in the global marketplace. However, recent legislation proposed in Congress has the potential to undermine the domestic tech sector and harm our economic and national security.
Read More